Gabrielle M. Etzel is the healthcare policy reporter for the Washington Examiner. Prior to joining the Washington Examiner, she served as a staff reporter at Campus Reform and as a freelance writer.
The Food and Drug Administration on Friday issued a warning to consumers to not purchase or immediately discontinue use of 26 over-the-counter eye drops due to possible risk of eye infections, potentially leading to partial vision loss or blindness.
FDA investigators found unsanitary conditions at the manufacturing plant shared by the various generic eye drop brands, including bacteria in"critical drug production areas in the facility."The products under emergency recall are marketed as CVS, Rite Aid, Target Up&Up generic products, as well as those under the Leader, Rugby, and Velocity Pharma brands.
Agency regulators said in their advisory that they urged the brands to remove their products as early as Wednesday, and that CVS, Rite Aid, and Target had already begun complying. Eye drops and other ophthalmic products"pose a potential heightened risk of harm to users because drugs applied to the eyes bypass some of the body's natural defenses," according to the FDA statement.No adverse events had been reported to the FDA as of Friday.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Gavin Newsom’s not-so-excellent Chinese adventureWashington Examiner
Baca lebih lajut »
Reporter's Notebook: How inflation has affected mortgage ratesWashington Examiner Staff
Baca lebih lajut »
Donald Trump gag order reinstated after recent string of commentsConrad Hoyt is the overnight news editor at the Washington Examiner.
Baca lebih lajut »
The kids are not all rightWashington Examiner
Baca lebih lajut »
Kamala Harris explains close 2024 polling with Trump and predicts future: 'We're going to win'Conrad Hoyt is the overnight news editor at the Washington Examiner.
Baca lebih lajut »